Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Events

  Events

June 2013
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
21 May 2013 - 27 Jun 2013
Live-on-the-Web
LC/MS Fundamentals and Applications
More information
European Lab Automation 2013 - ELA
06 Jun 2013 - 07 Jun 2013
Hamburg, Germany
European Lab Automation 2013 - ELA
More information
4th Aggregate Spend and Sunshine Act Compliance
11 Jun 2013 - 12 Jun 2013
Philadelphia, PA, USA
4th Aggregate Spend and Sunshine Act Compliance
More information
12 Jun 2013 - 14 Jun 2013
London, UK
Tablet Process Development, Validation and the application of QbD
More information
19 Jun 2013 - 21 Jun 2013
The Revere Hotel, Boston, MA USA
CHI's Structure-Based Drug Design
More information
CHI
19 Jun 2013 - 21 Jun 2013
Boston, MA, USA
CHI's Structure-Based Drug Design
More information
20 Jun 2013 - 21 Jun 2013
Edinburgh, UK
QbD Lifecycle Management for Analytical Methods
More information
26 Jun 2013 - 28 Jun 2013
London, UK
Technology Transfer
More information
International Congress of Toxicology
30 Jun 2013 - 04 Jul 2013
Coex, Seoul, Korea
International Congress of Toxicology
More information
<< 1 >>
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters